Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Affinity Chromatography01:03

Affinity Chromatography

3.4K
Affinity chromatography is a powerful technique extensively utilized for separating and purifying specific biomolecules from complex mixtures. It capitalizes on the highly selective binding between an analyte and its counterpart, such as antibody-antigen interactions. The counterpart is immobilized on the stationary phase, forming an affinity column. The stationary phase typically consists of solid support, such as agarose or porous glass beads, immobilizing the affinity ligand. The mobile...
3.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effects of chronic social stress on cognitive flexibility in adult female macaques.

bioRxiv : the preprint server for biology·2025
Same author

Structural Effects of Low Social Status and Obesogenic Diet on Social and Emotional Neurocircuits in Female Macaques: A Longitudinal Study from Infancy to Adulthood.

bioRxiv : the preprint server for biology·2025
Same author

A multicenter double-blind, placebo-controlled randomized trial to evaluate the safety and efficacy of bovine colostrum in the treatment of severe alcoholic hepatitis (SAH).

Trials·2023
Same author

Author Correction: High-affinity chromodomains engineered for improved detection of histone methylation and enhanced CRISPR-based gene repression.

Nature communications·2022
Same author

High-affinity chromodomains engineered for improved detection of histone methylation and enhanced CRISPR-based gene repression.

Nature communications·2022
Same author

Sorafenib induced hepatic encephalopathy.

Acta gastro-enterologica Belgica·2018

Related Experiment Video

Updated: Mar 17, 2026

Mapping Dysfunctional Protein-Protein Interactions in Disease
09:39

Mapping Dysfunctional Protein-Protein Interactions in Disease

Published on: October 24, 2025

979

Animal-Friendly Affinity Reagents: Replacing the Needless in the Haystack.

A C Gray1, S S Sidhu2, P C Chandrasekera3

  • 1AFABILITY, Morzine, France.

Trends in Biotechnology
|July 25, 2016
PubMed
Summary
This summary is machine-generated.

Animal-friendly affinity reagents (AFAs) offer alternatives to animal immunization for antibody production. This study proposes an EU-led strategy to implement these alternatives, reducing animal use in the antibody industry.

Keywords:
3RsAFAsDirective 2010/63/EUalternatives to animalsanimal welfareanimal-friendly affinity reagentsantibodiesmonoclonalpolyclonal

More Related Videos

Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples
13:21

Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples

Published on: May 4, 2012

16.4K
Semi-automated Biopanning of Bacterial Display Libraries for Peptide Affinity Reagent Discovery and Analysis of Resulting Isolates
13:49

Semi-automated Biopanning of Bacterial Display Libraries for Peptide Affinity Reagent Discovery and Analysis of Resulting Isolates

Published on: December 6, 2017

12.1K

Related Experiment Videos

Last Updated: Mar 17, 2026

Mapping Dysfunctional Protein-Protein Interactions in Disease
09:39

Mapping Dysfunctional Protein-Protein Interactions in Disease

Published on: October 24, 2025

979
Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples
13:21

Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples

Published on: May 4, 2012

16.4K
Semi-automated Biopanning of Bacterial Display Libraries for Peptide Affinity Reagent Discovery and Analysis of Resulting Isolates
13:49

Semi-automated Biopanning of Bacterial Display Libraries for Peptide Affinity Reagent Discovery and Analysis of Resulting Isolates

Published on: December 6, 2017

12.1K

Area of Science:

  • Biotechnology
  • Immunology
  • Regulatory Science

Background:

  • The global antibody industry relies heavily on animal immunization, utilizing millions of animals annually.
  • Despite the availability of advanced animal-friendly affinity reagents (AFAs) like those from naïve B lymphocyte and synthetic recombinant phage display technologies, animal use persists.
  • This reliance overlooks significant opportunities for animal use reduction.

Purpose of the Study:

  • To address the continued use of animals in antibody production despite viable alternatives.
  • To advocate for the implementation of Directive 2010/63/EU, which mandates the use of alternatives when available.
  • To propose an EU-led strategy for replacing animal-based antibody production.

Main Methods:

  • Analysis of current antibody production practices and the availability of animal-friendly affinity reagents (AFAs).
  • Engagement in discussions with the EU Reference Laboratory for alternatives to animal testing (EURL ECVAM) and the Directorate General for Environment.
  • Development of a proposed EU-led replacement strategy for antibody production.

Main Results:

  • Identified a significant gap between the availability of animal-friendly alternatives and their adoption in the antibody industry.
  • Initiated dialogue with key EU regulatory bodies to foster a strategy for implementing Directive 2010/63/EU.
  • Outlined necessary measures including avoiding outsourcing, regulating commercial production, and supporting antibody producers.

Conclusions:

  • The antibody industry must transition towards animal-friendly affinity reagents (AFAs) to comply with ethical and regulatory standards.
  • An EU-led strategy is crucial for facilitating the widespread adoption of alternatives and reducing animal use.
  • Regulatory measures and industry support are essential for a successful shift away from animal immunization.